Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Identification of a Plasmin-Interactive Site in the Factor VIII Light Chain Responsible for Proteolytic Cleavage at Lys36 in the A1 Domain.

Keiji Nogami, MD, PhD, Midori Shima, MD,PhD, Masahiro Takeyama, MD, Kohei Tatsumi, MD, Yuri Fujita, MD, Evgueni L. Saenko, PhD, Ichiro Tanaka, MD,PhD, Akira Yoshioka, MD,PhD

Blood (2006) 108 (11): 1709.

https://doi.org/10.1182/blood.V108.11.1709.1709

Published: 2006

Journal Articles

Identification of a Thrombin-Interactive Site within Factor VIII A2 Domain Responsible for the Cleavage at Arg372.

Keiji Nogami, MD, PhD, Midori Shima, MD,PhD, Evgueni L. Saenko, PhD, Masahiro Takeyama, MD, Kohei Tatsumi, MD, Yuri Fujita, MD, Ichiro Tanaka, MD,PhD, Akira Yoshioka, MD,PhD

Blood (2006) 108 (11): 1710.

https://doi.org/10.1182/blood.V108.11.1710.1710

Published: 2006

Journal Articles

Localization of Binding Sites for Low-Density Lipoprotein Receptor in Coagulation Factor VIII.

Evgeny M. Makogonenko, PhD, Andrey G. Sarafanov, PhD, Natalya M. Ananyeva, PhD, Dudley K. Strickland, PhD, Evgueni L. Saenko, PhD

Blood (2005) 106 (11): 1013.

https://doi.org/10.1182/blood.V106.11.1013.1013

Published: 2005

Journal Articles

B Domain of Coagulation Factor VIII Regulates Exposure of Its Heparin-Binding Site.

Evgeny M. Makogonenko, PhD, Andrey G. Sarafanov, PhD, Natalya M. Ananyeva, PhD, Klaus-Peter Radtke, PhD, Dudley K. Strickland, PhD, Evgueni L. Saenko, PhD

Blood (2005) 106 (11): 1014.

https://doi.org/10.1182/blood.V106.11.1014.1014

Published: 2005

Journal Articles

Identification of a Plasmin-Interactive Site within the A2 Domain of the Factor VIII Heavy Chain.

Keiji Nogami, MD, PhD, Midori Shima, MD, PhD, Katsumi Nishiya, MD, Evgueni L. Saenko, PhD, Masahiro Takeyama, MD, Kohei Tatsumi, MD, Ichiro Tanaka, MD, PhD, Akira Yoshioka, MD, PhD

Blood (2005) 106 (11): 1018.

https://doi.org/10.1182/blood.V106.11.1018.1018

Published: 2005

Journal Articles

Fragments of Activated Coagulation Factor VIII Bind to Multiple Sites within Low-Density Lipoprotein Receptor-Related Protein.

Andrey G. Sarafanov, PhD, Evgeny M. Makogonenko, PhD, Olav M. Andersen, PhD, Alexey V. Khrenov, PhD, Irina A. Mikhailenko, PhD, Natalya M. Ananyeva, PhD, Dudley K. Strickland, PhD, Evgueni L. Saenko, PhD

Blood (2005) 106 (11): 1019.

https://doi.org/10.1182/blood.V106.11.1019.1019

Published: 2005

Journal Articles

Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque

Natalya M. Ananyeva, Diana V. Kouiavskaia, Midori Shima, Evgueni L. Saenko

Blood (2002) 99 (12): 4475–4485.

https://doi.org/10.1182/blood-2001-11-0140

Published: 2002

Journal Articles

A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C–catalyzed inactivation

Keiji Nogami, Midori Shima, Katsumi Nishiya, Kazuya Hosokawa, Evgueni L. Saenko, Yoshihiko Sakurai, Masaru Shibata, Hiroshi Suzuki, Ichiro Tanaka, Akira Yoshioka

Blood (2002) 99 (11): 3993–3998.

https://doi.org/10.1182/blood.V99.11.3993

Published: 2002

Journal Articles

Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa

Steven W. Pipe, Evgueni L. Saenko, Angela N. Eickhorst, Geoffrey Kemball-Cook, Randal J. Kaufman

Blood (2001) 97 (3): 685–691.

https://doi.org/10.1182/blood.V97.3.685

Published: 2001

Journal Articles

Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C–mediated proteolysis

Keiji Nogami, Midori Shima, John C. Giddings, Kazuya Hosokawa, Masanori Nagata, Seiki Kamisue, Hiroshi Suzuki, Masaru Shibata, Evgueni L. Saenko, Ichiro Tanaka, Akira Yoshioka

Blood (2001) 97 (3): 669–677.

https://doi.org/10.1182/blood.V97.3.669

Published: 2001

Journal Articles

Some Human Inhibitor Antibodies Interfere With Factor VIII Binding to Factor IX

Degang Zhong, Evgueni L. Saenko, Midori Shima, Matthew Felch, Dorothea Scandella

Blood (1998) 92 (1): 136–142.

https://doi.org/10.1182/blood.V92.1.136.413k35_136_142

Published: 1998

Journal Articles

Loss of Tolerance to Exogenous and Endogenous Factor VIII in a Mild Hemophilia A Patient With an Arg 593 to Cys Mutation

Arthur R. Thompson, Michael E.P. Murphy, MiaoLiang Liu, Evgueni L. Saenko, John F. Healey, Pete Lollar, Dorothea Scandella

Blood (1997) 90 (5): 1902–1910.

https://doi.org/10.1182/blood.V90.5.1902

Published: 1997

Journal Articles

The Inhibitor Antibody Response Is More Complex in Hemophilia A Patients Than in Most Nonhemophiliacs With Factor VIII Autoantibodies

Richard Prescott, Hiroaki Nakai, Evgueni L. Saenko, Inge Scharrer, Inga Marie Nilsson, John E. Humphries, Deborah Hurst, Gordon Bray, Dorothea Scandella, the Recombinate and Kogenate Study Groups

Blood (1997) 89 (10): 3663–3671.

https://doi.org/10.1182/blood.V89.10.3663

Published: 1997

NARROW

Identification of a Plasmin-Interactive Site in the Factor VIII Light Chain Responsible for Proteolytic Cleavage at Lys36 in the A1 Domain.

Identification of a Thrombin-Interactive Site within Factor VIII A2 Domain Responsible for the Cleavage at Arg372.

Localization of Binding Sites for Low-Density Lipoprotein Receptor in Coagulation Factor VIII.

B Domain of Coagulation Factor VIII Regulates Exposure of Its Heparin-Binding Site.

Identification of a Plasmin-Interactive Site within the A2 Domain of the Factor VIII Heavy Chain.

Fragments of Activated Coagulation Factor VIII Bind to Multiple Sites within Low-Density Lipoprotein Receptor-Related Protein.

Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque

A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C–catalyzed inactivation

Hemophilia A mutations associated with 1-stage/2-stage activity discrepancy disrupt protein-protein interactions within the triplicated A domains of thrombin-activated factor VIIIa

Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C–mediated proteolysis

Some Human Inhibitor Antibodies Interfere With Factor VIII Binding to Factor IX

Loss of Tolerance to Exogenous and Endogenous Factor VIII in a Mild Hemophilia A Patient With an Arg 593 to Cys Mutation

The Inhibitor Antibody Response Is More Complex in Hemophilia A Patients Than in Most Nonhemophiliacs With Factor VIII Autoantibodies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only